$ELTP Recent News Former CEO of Elite Pharmace
Post# of 250602
Posted On: 01/26/2016 1:47:36 AM
$ELTP Recent News
Former CEO of Elite Pharmaceuticals sells all shares 9:46 a.m. Oct. 28, 2004 - James Comtois
Semel's Yahoo stock sales lead weekly insider trades 3:17 p.m. Oct. 25, 2004 - James Comtois
Elite Pharma says ends Nostrum Pharma merger talks 4:18 p.m. Aug. 6, 2004 - Carla Mozee
Elite Pharmaceuticals settles w/former CEO 11:07 a.m. May 3, 2004 - Maggie McNeil
Elite settles w/former CEO, includes $400,000 payment 12:15 p.m. April 1, 2004 - Maggie McNeil
Elite Pharma to negotiate purchase of Nostrum 1:26 p.m. Aug. 8, 2003 - Chris Kraeuter
10-Q/A: ELITE PHARMACEUTICALS INC /NV/ 4:25 p.m. Dec. 30, 2015 - Edgar Online - (EDG = 10Q, 10K)
10-Q/A: ELITE PHARMACEUTICALS INC /NV/ 4:15 p.m. Dec. 30, 2015 - Edgar Online - (EDG = 10Q, 10K)
10-Q/A: ELITE PHARMACEUTICALS INC /NV/ 4:34 p.m. Nov. 10, 2015 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2015 Results - Earnings Call Transcript 3:46 p.m. Nov. 10, 2015 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 5:03 p.m. Nov. 9, 2015 - Edgar Online - (EDG = 10Q, 10K)
Premarket Biotech Digest: Citron's Attack On Valeant, Biogen Beats, Northwest Secures Funding 8:15 a.m. Oct. 22, 2015 - Seeking Alpha
Elite Pharma's ELI-200 successful in late-stage study in post-surgical pain 9:04 a.m. Oct. 21, 2015 - Seeking Alpha
Elite Pharmaceutical's (ELTP) CEO Nasrat Hakim on Q1 2016 Results - Earnings Call Transcript 1:46 p.m. Aug. 11, 2015 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 3:28 p.m. Aug. 10, 2015 - Edgar Online - (EDG = 10Q, 10K)
All subjects enrolled and dosed in Elite Pharma's late-stage trial of abuse-deterrent opioid 9:12 a.m. Aug. 3, 2015 - Seeking Alpha
Elite Pharmaceutical's (ELTP) CEO Nasrat Hakim on Q4 2015 Results - Earnings Call Transcript 7:50 p.m. June 16, 2015 - Seeking Alpha
10-K: ELITE PHARMACEUTICALS INC /NV/ 3:37 p.m. June 15, 2015 - Edgar Online - (EDG = 10Q, 10K)
FDA accepts Teva's NDA for abuse-deterrent opioid 9:42 a.m. Feb. 25, 2015 - Seeking Alpha
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2015 - Earnings Call Transcript 3:31 p.m. Feb. 18, 2015 - Seeking Alpha
Elite Pharma set to begin abuse-deterrent opioid Phase 3 trial 10:06 p.m. Feb. 17, 2015 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 4:43 p.m. Feb. 17, 2015 - Edgar Online - (EDG = 10Q, 10K)
IHUB Most Posted And Most Read Stocks Do Not Perform Well 9:43 a.m. Feb. 11, 2015 - Seeking Alpha
Zogenix Approval Sheds Light On Path For Elite Pharmaceuticals 8:00 a.m. Feb. 6, 2015 - Seeking Alpha
Elite Pharmaceuticals Is Well Positioned To Address $7B Abuse Deterrent Opioid Market 8:06 a.m. Jan. 29, 2015 - Seeking Alpha
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2015 Results - Earnings Call Transcript 5:49 p.m. Nov. 19, 2014 - Seeking Alpha
Traders Look to Upside - Analyst Research on SandRidge Energy, Elite Pharmaceuticals, Dyadic International and Accretive Health 9:34 a.m. Jan. 21, 2016 - ACCESSWIRE
Today's Market Driven by Key Factors - New Research on Trans-Pacific Aerospace Company, Elite Pharmaceuticals, First Mining Finance and Golden Queen Mining 8:30 a.m. Jan. 14, 2016 - ACCESSWIRE
FDA Approves Waiver of NDA Filing Fee for Elite Pharmaceuticals 4:52 p.m. Jan. 13, 2016 - GlobeNewswire
Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals 9:25 a.m. Jan. 13, 2016 - GlobeNewswire
Equity Market Movement at a Glance - Research on Northwest Biotherapeutics, Elite Pharmaceuticals, Ekso Bionics Holdings, and Medical Marijuana 8:10 a.m. Nov. 24, 2015 - ACCESSWIRE
The Price Data Tells the Story - Research on Northwest Biotherapeutics, Elite Pharmaceuticals, Barrett Business Services and Ekso Bionics Holdings 8:02 a.m. Nov. 16, 2015 - ACCESSWIRE
Direction of Market Influences - Research on PositiveID, Elite Pharmaceuticals, Century Communities and Innerworkings 8:25 a.m. Nov. 12, 2015 - ACCESSWIRE
Elite Pharmaceuticals, Inc. Reports Strong Growth for Second Quarter of Fiscal Year 2016 4:38 p.m. Nov. 9, 2015 - GlobeNewswire
Equities Lead Investor Sentiment - Research on Elite Pharmaceuticals, Medical Marijuana, Ekso Bionics Holdings and Pharmacyte Biotech 7:45 a.m. Nov. 9, 2015 - ACCESSWIRE
Equities Lead Investor Sentiment - Research on PositiveID, Elite Pharmaceuticals, Century Communities and iShares PHLX Semiconductor 7:45 a.m. Nov. 5, 2015 - ACCESSWIRE
Direction of Market Influences - Research on Pharmacyte Biotech, NuGene International, Rainbow Coral Corp and Elite Pharmaceuticals 8:40 a.m. Nov. 2, 2015 - ACCESSWIRE
The Reason It Trades, Quarterly Results, Project Financing and Strategic Acquisitions - Research on Dominovas Energy, Priority Aviation, Elite Pharmaceuticals, PositiveID 7:01 a.m. Oct. 29, 2015 - ACCESSWIRE
Be On Top Of the Latest Developments - Research on Elite Pharmaceuticals, NanoTech Entertainment, Medbox and Bioelectronics 7:00 a.m. Oct. 28, 2015 - ACCESSWIRE
Elite Pharmaceuticals Announces Positive Top-Line Results From a Pivotal Phase 3 Study for Abuse-Deterrent Opioid ELI-200 7:00 a.m. Oct. 21, 2015 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Record Revenues for First Quarter of Fiscal Year 2016 3:20 p.m. Aug. 10, 2015 - GlobeNewswire
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology 9:33 a.m. June 16, 2015 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2015 3:58 p.m. June 15, 2015 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on Wednesday, February 18, 2015 2:49 p.m. Feb. 12, 2015 - GlobeNewswire
Former CEO of Elite Pharmaceuticals sells all shares 9:46 a.m. Oct. 28, 2004 - James Comtois
Semel's Yahoo stock sales lead weekly insider trades 3:17 p.m. Oct. 25, 2004 - James Comtois
Elite Pharma says ends Nostrum Pharma merger talks 4:18 p.m. Aug. 6, 2004 - Carla Mozee
Elite Pharmaceuticals settles w/former CEO 11:07 a.m. May 3, 2004 - Maggie McNeil
Elite settles w/former CEO, includes $400,000 payment 12:15 p.m. April 1, 2004 - Maggie McNeil
Elite Pharma to negotiate purchase of Nostrum 1:26 p.m. Aug. 8, 2003 - Chris Kraeuter
10-Q/A: ELITE PHARMACEUTICALS INC /NV/ 4:25 p.m. Dec. 30, 2015 - Edgar Online - (EDG = 10Q, 10K)
10-Q/A: ELITE PHARMACEUTICALS INC /NV/ 4:15 p.m. Dec. 30, 2015 - Edgar Online - (EDG = 10Q, 10K)
10-Q/A: ELITE PHARMACEUTICALS INC /NV/ 4:34 p.m. Nov. 10, 2015 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2015 Results - Earnings Call Transcript 3:46 p.m. Nov. 10, 2015 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 5:03 p.m. Nov. 9, 2015 - Edgar Online - (EDG = 10Q, 10K)
Premarket Biotech Digest: Citron's Attack On Valeant, Biogen Beats, Northwest Secures Funding 8:15 a.m. Oct. 22, 2015 - Seeking Alpha
Elite Pharma's ELI-200 successful in late-stage study in post-surgical pain 9:04 a.m. Oct. 21, 2015 - Seeking Alpha
Elite Pharmaceutical's (ELTP) CEO Nasrat Hakim on Q1 2016 Results - Earnings Call Transcript 1:46 p.m. Aug. 11, 2015 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 3:28 p.m. Aug. 10, 2015 - Edgar Online - (EDG = 10Q, 10K)
All subjects enrolled and dosed in Elite Pharma's late-stage trial of abuse-deterrent opioid 9:12 a.m. Aug. 3, 2015 - Seeking Alpha
Elite Pharmaceutical's (ELTP) CEO Nasrat Hakim on Q4 2015 Results - Earnings Call Transcript 7:50 p.m. June 16, 2015 - Seeking Alpha
10-K: ELITE PHARMACEUTICALS INC /NV/ 3:37 p.m. June 15, 2015 - Edgar Online - (EDG = 10Q, 10K)
FDA accepts Teva's NDA for abuse-deterrent opioid 9:42 a.m. Feb. 25, 2015 - Seeking Alpha
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q3 2015 - Earnings Call Transcript 3:31 p.m. Feb. 18, 2015 - Seeking Alpha
Elite Pharma set to begin abuse-deterrent opioid Phase 3 trial 10:06 p.m. Feb. 17, 2015 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 4:43 p.m. Feb. 17, 2015 - Edgar Online - (EDG = 10Q, 10K)
IHUB Most Posted And Most Read Stocks Do Not Perform Well 9:43 a.m. Feb. 11, 2015 - Seeking Alpha
Zogenix Approval Sheds Light On Path For Elite Pharmaceuticals 8:00 a.m. Feb. 6, 2015 - Seeking Alpha
Elite Pharmaceuticals Is Well Positioned To Address $7B Abuse Deterrent Opioid Market 8:06 a.m. Jan. 29, 2015 - Seeking Alpha
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2015 Results - Earnings Call Transcript 5:49 p.m. Nov. 19, 2014 - Seeking Alpha
Traders Look to Upside - Analyst Research on SandRidge Energy, Elite Pharmaceuticals, Dyadic International and Accretive Health 9:34 a.m. Jan. 21, 2016 - ACCESSWIRE
Today's Market Driven by Key Factors - New Research on Trans-Pacific Aerospace Company, Elite Pharmaceuticals, First Mining Finance and Golden Queen Mining 8:30 a.m. Jan. 14, 2016 - ACCESSWIRE
FDA Approves Waiver of NDA Filing Fee for Elite Pharmaceuticals 4:52 p.m. Jan. 13, 2016 - GlobeNewswire
Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals 9:25 a.m. Jan. 13, 2016 - GlobeNewswire
Equity Market Movement at a Glance - Research on Northwest Biotherapeutics, Elite Pharmaceuticals, Ekso Bionics Holdings, and Medical Marijuana 8:10 a.m. Nov. 24, 2015 - ACCESSWIRE
The Price Data Tells the Story - Research on Northwest Biotherapeutics, Elite Pharmaceuticals, Barrett Business Services and Ekso Bionics Holdings 8:02 a.m. Nov. 16, 2015 - ACCESSWIRE
Direction of Market Influences - Research on PositiveID, Elite Pharmaceuticals, Century Communities and Innerworkings 8:25 a.m. Nov. 12, 2015 - ACCESSWIRE
Elite Pharmaceuticals, Inc. Reports Strong Growth for Second Quarter of Fiscal Year 2016 4:38 p.m. Nov. 9, 2015 - GlobeNewswire
Equities Lead Investor Sentiment - Research on Elite Pharmaceuticals, Medical Marijuana, Ekso Bionics Holdings and Pharmacyte Biotech 7:45 a.m. Nov. 9, 2015 - ACCESSWIRE
Equities Lead Investor Sentiment - Research on PositiveID, Elite Pharmaceuticals, Century Communities and iShares PHLX Semiconductor 7:45 a.m. Nov. 5, 2015 - ACCESSWIRE
Direction of Market Influences - Research on Pharmacyte Biotech, NuGene International, Rainbow Coral Corp and Elite Pharmaceuticals 8:40 a.m. Nov. 2, 2015 - ACCESSWIRE
The Reason It Trades, Quarterly Results, Project Financing and Strategic Acquisitions - Research on Dominovas Energy, Priority Aviation, Elite Pharmaceuticals, PositiveID 7:01 a.m. Oct. 29, 2015 - ACCESSWIRE
Be On Top Of the Latest Developments - Research on Elite Pharmaceuticals, NanoTech Entertainment, Medbox and Bioelectronics 7:00 a.m. Oct. 28, 2015 - ACCESSWIRE
Elite Pharmaceuticals Announces Positive Top-Line Results From a Pivotal Phase 3 Study for Abuse-Deterrent Opioid ELI-200 7:00 a.m. Oct. 21, 2015 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Record Revenues for First Quarter of Fiscal Year 2016 3:20 p.m. Aug. 10, 2015 - GlobeNewswire
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology 9:33 a.m. June 16, 2015 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2015 3:58 p.m. June 15, 2015 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on Wednesday, February 18, 2015 2:49 p.m. Feb. 12, 2015 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼